These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14989386)

  • 41. Omalizumab treatment associated with Churg-Strauss vasculitis.
    Bargagli E; Rottoli P
    Int Arch Allergy Immunol; 2008; 145(3):268. PubMed ID: 17921677
    [No Abstract]   [Full Text] [Related]  

  • 42. Systemic reaction to omalizumab.
    Chipps B
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):267. PubMed ID: 16937765
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Churg-Strauss vasculitis in a patient treated with omalizumab.
    Bargagli E; Madioni C; Olivieri C; Penza F; Rottoli P
    J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
    Lin RY; Rodriguez-Baez G; Bhargave GA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent severe asthma and aging: step-up therapy with omalizumab to improve control.
    Greenberger PA
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):408-10. PubMed ID: 21130375
    [No Abstract]   [Full Text] [Related]  

  • 47. Effectiveness of omalizumab in monozygotic twin sisters with severe allergic asthma.
    Just J; Sahraoui F; Le Gros V; Grimfeld A
    Allergy; 2007 Apr; 62(4):453-4. PubMed ID: 17362261
    [No Abstract]   [Full Text] [Related]  

  • 48. Omalizumab for severe allergic asthma: dollars and sense.
    Krishnan JA; Gould M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1015-7. PubMed ID: 17983869
    [No Abstract]   [Full Text] [Related]  

  • 49. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.
    Maykut RJ; Kianifard F; Geba GP
    J Asthma; 2008 Apr; 45(3):173-81. PubMed ID: 18415822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
    Massanari M; Nelson H; Casale T; Busse W; Kianifard F; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2010 Feb; 125(2):383-9. PubMed ID: 20159249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and interpretability of skin tests with omalizumab.
    Lieberman P; Rahmaoui A; Wong DA
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):493-5. PubMed ID: 21130393
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of an anaphylactoid reaction to omalizumab.
    Dreyfus DH; Randolph CC
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma.
    Limb SL; Starke PR; Lee CE; Chowdhury BA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1378-81. PubMed ID: 17936893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe serum sickness-like syndrome after omalizumab therapy for asthma.
    Pilette C; Coppens N; Houssiau FA; Rodenstein DO
    J Allergy Clin Immunol; 2007 Oct; 120(4):972-3. PubMed ID: 17716723
    [No Abstract]   [Full Text] [Related]  

  • 56. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of omalizumab and steroids in Churg-Strauss syndrome.
    Spina MF; Miadonna A
    J Allergy Clin Immunol; 2009 Sep; 124(3):600-1. PubMed ID: 19631973
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
    Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omalizumab: efficacy in allergic disease.
    Spector S
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.